Clinical trials at Memorial Sloan Kettering may give you access to new therapies that aren’t widely available. These research studies evaluate the safety and effectiveness of new ways to diagnose and treat cervical cancer. They can also give your treatment team information about your current plan of care.
Our clinical research team is highly experienced in selecting women who are mostly likely to benefit from a particular investigational therapy and in guiding patients through the process of enrolling in the most appropriate clinical trial. If you are eligible to participate in a clinical trial, you may have access to new therapies that are not yet widely available.
A number of our trials focus on current standards for treatment and enhance survival and quality of life. These trials are done through our research programs as well as through the efforts of the Gynecologic Oncology Group, a multi-institutional clinical research effort supported by the National Cancer Institute.
Additional studies are under way to identify vaccines that target other types of HPV linked to cervical cancer, help your immune system destroy HPV if you’re already infected, and offer new treatments if you have advanced or recurrent cervical cancer. Ask your treatment team if you’re interested in learning more about these vaccines.
The following cervical cancer clinical trials at Memorial Sloan Kettering are currently enrolling patients. To learn more about a study, choose from the list below.